A detailed history of Platinum Investment Management LTD transactions in Merus N.V. stock. As of the latest transaction made, Platinum Investment Management LTD holds 69,085 shares of MRUS stock, worth $3.43 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
69,085
Previous 73,722 6.29%
Holding current value
$3.43 Million
Previous $4.36 Million 20.88%
% of portfolio
0.16%
Previous 0.18%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$47.19 - $58.84 $218,820 - $272,841
-4,637 Reduced 6.29%
69,085 $3.45 Million
Q2 2024

Aug 12, 2024

SELL
$39.81 - $60.2 $1.03 Million - $1.55 Million
-25,768 Reduced 25.9%
73,722 $4.36 Million
Q1 2024

May 13, 2024

SELL
$28.03 - $51.82 $1.19 Million - $2.2 Million
-42,539 Reduced 29.95%
99,490 $4.48 Million
Q3 2023

Nov 02, 2023

SELL
$20.13 - $27.29 $165,247 - $224,023
-8,209 Reduced 5.46%
142,029 $3.35 Million
Q2 2023

Aug 10, 2023

SELL
$18.33 - $27.18 $1.63 Million - $2.41 Million
-88,814 Reduced 37.15%
150,238 $3.96 Million
Q1 2023

May 11, 2023

BUY
$14.25 - $20.5 $679,682 - $977,788
47,697 Added 24.93%
239,052 $4.4 Million
Q4 2022

Feb 13, 2023

BUY
$12.8 - $23.66 $577,164 - $1.07 Million
45,091 Added 30.83%
191,355 $2.96 Million
Q3 2022

Nov 14, 2022

BUY
$18.64 - $28.93 $63,450 - $98,477
3,404 Added 2.38%
146,264 $2.93 Million
Q2 2022

Aug 11, 2022

SELL
$13.98 - $29.25 $194,895 - $407,774
-13,941 Reduced 8.89%
142,860 $3.23 Million
Q1 2022

May 13, 2022

SELL
$23.58 - $30.91 $464,714 - $609,174
-19,708 Reduced 11.17%
156,801 $4.15 Million
Q4 2021

Feb 11, 2022

SELL
$20.0 - $32.29 $1.27 Million - $2.05 Million
-63,528 Reduced 26.47%
176,509 $5.61 Million
Q3 2021

Nov 09, 2021

BUY
$16.48 - $27.23 $413,038 - $682,465
25,063 Added 11.66%
240,037 $5.28 Million
Q1 2021

May 13, 2021

SELL
$16.14 - $29.11 $230,140 - $415,079
-14,259 Reduced 6.22%
214,974 $4.49 Million
Q4 2020

Feb 12, 2021

BUY
$11.4 - $18.36 $442,605 - $712,827
38,825 Added 20.39%
229,233 $4.02 Million
Q2 2020

Aug 06, 2020

SELL
$10.5 - $17.36 $234,622 - $387,909
-22,345 Reduced 10.5%
190,408 $3.06 Million
Q1 2020

May 15, 2020

BUY
$11.34 - $19.44 $483,548 - $828,941
42,641 Added 25.07%
212,753 $2.57 Million
Q4 2019

Feb 13, 2020

BUY
$14.08 - $18.5 $436,648 - $573,722
31,012 Added 22.29%
170,112 $2.4 Million
Q3 2019

Nov 14, 2019

SELL
$14.55 - $20.52 $549,044 - $774,322
-37,735 Reduced 21.34%
139,100 $2.48 Million
Q1 2019

May 15, 2019

BUY
$11.09 - $15.83 $256,933 - $366,749
23,168 Added 15.08%
176,835 $2.61 Million
Q4 2018

Feb 14, 2019

BUY
$11.46 - $20.81 $589,594 - $1.07 Million
51,448 Added 50.33%
153,667 $2.15 Million
Q2 2017

Aug 15, 2017

BUY
N/A
102,219
102,219 $1.62 Million

Others Institutions Holding MRUS

About Merus N.V.


  • Ticker MRUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,878,200
  • Market Cap $2.28B
  • Description
  • Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...
More about MRUS
Track This Portfolio

Track Platinum Investment Management LTD Portfolio

Follow Platinum Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Platinum Investment Management LTD with notifications on news.